相似文献
1
Synthesis, antimalarial activity, and structure-activity relationship of 7-(2-phenoxyethoxy)-4(1H)-quinolones.
J Med Chem. 2011 Dec 22;54(24):8321-7. doi: 10.1021/jm200718m. Epub 2011 Nov 23.
2
ICI 56,780 Optimization: Structure-Activity Relationship Studies of 7-(2-Phenoxyethoxy)-4(1H)-quinolones with Antimalarial Activity.
J Med Chem. 2016 Jul 28;59(14):6943-60. doi: 10.1021/acs.jmedchem.6b00759. Epub 2016 Jul 12.
3
Endochin optimization: structure-activity and structure-property relationship studies of 3-substituted 2-methyl-4(1H)-quinolones with antimalarial activity.
J Med Chem. 2010 Oct 14;53(19):7076-94. doi: 10.1021/jm1007903.
4
Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
J Med Chem. 2012 Mar 8;55(5):1844-57. doi: 10.1021/jm201184h. Epub 2012 Feb 24.
5
Antimalarial quinolones: synthesis, potency, and mechanistic studies.
Exp Parasitol. 2008 Apr;118(4):487-97. doi: 10.1016/j.exppara.2007.10.016. Epub 2007 Nov 7.
6
Role of Trifluoromethyl Substitution in Design of Antimalarial Quinolones: a Comprehensive Review.
Top Curr Chem (Cham). 2019 Mar 5;377(2):9. doi: 10.1007/s41061-019-0234-7.
7
Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers.
J Med Chem. 2014 May 8;57(9):3818-34. doi: 10.1021/jm500147k. Epub 2014 Apr 18.
8
Synthesis and activity of some quinolone derivatives against Plasmodium falciparum in vitro.
Farmaco. 1996 Jun;51(6):407-12.
9
4-(1H)-Quinolones and 1,2,3,4-Tetrahydroacridin-9(10H)-ones prevent the transmission of Plasmodium falciparum to Anopheles freeborni.
Antimicrob Agents Chemother. 2013 Dec;57(12):6187-95. doi: 10.1128/AAC.00492-13. Epub 2013 Sep 30.
10
4(1H)-Quinolones with liver stage activity against Plasmodium berghei.
Antimicrob Agents Chemother. 2013 Jan;57(1):417-24. doi: 10.1128/AAC.00793-12. Epub 2012 Nov 5.
引用本文的文献
1
Quinoline derivatives' biological interest for anti-malarial and anti-cancer activities: an overview.
RSC Adv. 2025 Aug 27;15(37):30576-30604. doi: 10.1039/d5ra00534e. eCollection 2025 Aug 22.
2
Quinolone: a versatile therapeutic compound class.
Mol Divers. 2023 Jun;27(3):1501-1526. doi: 10.1007/s11030-022-10581-8. Epub 2022 Dec 17.
3
Self-assembly of new cobalt complexes based on [Co (SCN)], synthesis, empirical, antioxidant activity, and quantum theory investigations.
Sci Rep. 2022 Sep 22;12(1):15828. doi: 10.1038/s41598-022-18471-7.
4
Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1)-Quinolones with Single Dose Cures.
J Med Chem. 2021 May 27;64(10):6581-6595. doi: 10.1021/acs.jmedchem.0c01104. Epub 2021 May 12.
5
Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure-Activity and Structure-Property Relationship Studies.
J Med Chem. 2018 Feb 22;61(4):1450-1473. doi: 10.1021/acs.jmedchem.7b00738. Epub 2018 Feb 9.
6
Progress in the Optimization of 4(1)-Quinolone Derivatives as Antimalarials Targeting the Erythrocytic, the Exoerythrocytic and the Transmitting Stages of the Malaria Parasite.
Chimia (Aarau). 2017 Apr 26;71(4):213-219. doi: 10.2533/chimia.2017.213.
7
Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria?
Malar J. 2016 Nov 15;15(1):556. doi: 10.1186/s12936-016-1613-y.
8
ICI 56,780 Optimization: Structure-Activity Relationship Studies of 7-(2-Phenoxyethoxy)-4(1H)-quinolones with Antimalarial Activity.
J Med Chem. 2016 Jul 28;59(14):6943-60. doi: 10.1021/acs.jmedchem.6b00759. Epub 2016 Jul 12.
9
Computational Study of Quinolone Derivatives to Improve their Therapeutic Index as Anti-malaria Agents: QSAR and QSTR.
Iran J Pharm Res. 2015 Summer;14(3):775-84.
10
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
J Med Chem. 2014 Nov 13;57(21):8860-79. doi: 10.1021/jm500942v. Epub 2014 Oct 22.
本文引用的文献
1
Synthesis and antitrypanosomal evaluation of derivatives of N-benzyl-1,2-dihydroquinolin-6-ols: Effect of core substitutions and salt formation.
Bioorg Med Chem. 2011 Jan 1;19(1):513-23. doi: 10.1016/j.bmc.2010.11.003. Epub 2010 Nov 5.
2
Divergent route to access structurally diverse 4-quinolones via mono or sequential cross-couplings.
J Org Chem. 2010 Dec 17;75(24):8654-7. doi: 10.1021/jo1014504. Epub 2010 Nov 17.
3
Endochin optimization: structure-activity and structure-property relationship studies of 3-substituted 2-methyl-4(1H)-quinolones with antimalarial activity.
J Med Chem. 2010 Oct 14;53(19):7076-94. doi: 10.1021/jm1007903.
4
4-Quinolones: smart phones of the microbial world.
Chem Rev. 2011 Jan 12;111(1):152-9. doi: 10.1021/cr100063u. Epub 2010 Aug 11.
5
Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins.
Angew Chem Int Ed Engl. 2010 Aug 2;49(33):5693-7. doi: 10.1002/anie.201001026.
6
Synthesis and structure-activity relationships of antimalarial 4-oxo-3-carboxyl quinolones.
Bioorg Med Chem. 2010 Apr 1;18(7):2756-66. doi: 10.1016/j.bmc.2010.02.013. Epub 2010 Feb 11.
7
A pre-emptive strike against malaria's stealthy hepatic forms.
Nat Rev Drug Discov. 2009 Nov;8(11):854-64. doi: 10.1038/nrd2960.
8
New medicines to improve control and contribute to the eradication of malaria.
Nat Rev Drug Discov. 2009 Nov;8(11):879-91. doi: 10.1038/nrd2972. Epub 2009 Oct 16.
9
Artemisinin resistance in Plasmodium falciparum malaria.
N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859.
10
Antimalarial quinolones: synthesis, potency, and mechanistic studies.
Exp Parasitol. 2008 Apr;118(4):487-97. doi: 10.1016/j.exppara.2007.10.016. Epub 2007 Nov 7.
Zotero 插件